The market is in a grey area as technical conditions suggest a pullback would be in order but hopes of a trade deal with China prevent aggressive selling.
The government shutdown could have an impact on the FANG stocks.
Merck shares slipped lower in pre-market trading Wednesday after the drugmaker said one of its key liver cancer treatments failed a late-stage trial only months after getting accelerated approval from the U.S. Food & Drug Administration.
Mark Badgley and James Mischka discuss how tariffs are impacting handbags.
U.S. stock futures point to a weaker start for Wall Street on Wednesday, though there are increasing signs of tangible progress in U.S.-China trade talks; CVS and Avis report earnings; Elon Musk says Tesla will have the technology in place for a self-driving car by the end of the year.
Jim Cramer explains why he's worried about two of the FANG names. Hint: Divorce and Huawei.
Teva Pharmaceuticals shares were indicated lower in pre-market trading Wednesday after the drugmaker reached a settlement with the Federal Trade Commission over allegations it delayed the release of generic medicines through agreements with pharmaceutical rivals.
Walmart struggling U.K. subsidiary could be blocked from merging with a larger rival over concerns from the country's competition watchdog that the tie-up would lead to higher prices and a "poorer experience" for shoppers in Europe's second-largest market.